Literature DB >> 23498342

Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury.

Mandeep Pundir1, Shiyana Arora, Tajpreet Kaur, Randhir Singh, Amrit Pal Singh.   

Abstract

BACKGROUND: Acute kidney injury (AKI) is one of the major health problems in developed as well as developing countries. The literature regarding the role of N-methyl-D-aspartate receptors (NMDAR) and the impact of the modulation of its allosteric sites on renal function is inadequate. The present study investigated the effect of modulating allosteric sites of NMDAR in ischemia-reperfusion-induced AKI.
MATERIALS AND METHODS: We subjected rats to bilateral renal ischemia for 40 min followed by reperfusion for 24 h to induce AKI. We measured blood urea nitrogen, serum creatinine, uric acid, and lactate dehydrogenase to assess kidney injury. We assayed the thiobarbituric acid-reactive substances, reduced glutathione level, and myeloperoxidase and catalase activity to assess oxidative stress in renal tissue, and used hematoxylin-eosin staining to observe histopathologic changes.
RESULTS: Ischemia-reperfusion induced AKI, as demonstrated by an increase in serum parameters, oxidative stress and histopathologic changes in renal tissue. The NMDA agonist glutamic acid and polyamine binding site agonist spermidine significantly aggravated oxidative stress and ischemia-reperfusion-induced AKI. Various NMDA receptor antagonists, including glycine binding site inhibitor kynurenic acid, polyamine binding site inhibitor ketamine, and channel blocking agent magnesium sulfate, attenuated ischemia-reperfusion-induced AKI and significantly reduced oxidative stress, which suggests a role for NMDA receptors and the importance of regulating its allosteric sites in AKI.
CONCLUSIONS: Acute kidney injury is associated with the activation of NMDA receptors, as well as significant oxidative stress. The antagonism of various allosteric sites of NMDA receptors affords significant benefit against ischemia-reperfusion-induced AKI.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allosteric modulation; Ischemia-reperfusion; Kidney injury; NMDA

Mesh:

Substances:

Year:  2013        PMID: 23498342     DOI: 10.1016/j.jss.2013.01.040

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  18 in total

1.  Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury.

Authors:  Jing Ying; Jin Wu; Yiwei Zhang; Yangyang Han; Xinger Qian; Qiuhong Yang; Yongjie Chen; Yijun Chen; Hao Zhu
Journal:  Mol Cell Biochem       Date:  2019-11-16       Impact factor: 3.396

Review 2.  The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.

Authors:  Hai Ning Wee; Jian-Jun Liu; Jianhong Ching; Jean-Paul Kovalik; Su Chi Lim
Journal:  Am J Nephrol       Date:  2021-11-09       Impact factor: 3.754

3.  Estradiol mitigates ischemia reperfusion-induced acute renal failure through NMDA receptor antagonism in rats.

Authors:  Amrit Pal Singh; Nirmal Singh; Preet Mohinder Singh Bedi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

4.  Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats.

Authors:  Amrit Pal Singh; Nirmal Singh; Preet Mohinder Singh Bedi
Journal:  Mol Cell Biochem       Date:  2016-05-20       Impact factor: 3.396

5.  Glycine aggravates ischemia reperfusion-induced acute kidney injury through N-Methyl-D-Aspartate receptor activation in rats.

Authors:  Shiyana Arora; Tajpreet Kaur; Anudeep Kaur; Amrit Pal Singh
Journal:  Mol Cell Biochem       Date:  2014-04-17       Impact factor: 3.396

6.  Dioclea violacea lectin ameliorates oxidative stress and renal dysfunction in an experimental model of acute kidney injury.

Authors:  Flavia Ps Freitas; Marcella L Porto; Camilla P Tranhago; Rogerio Piontkowski; Emilio C Miguel; Thaiz Bar Miguel; Jorge L Martins; Kyria S Nascimento; Camille M Balarini; Benildo S Cavada; Silvana S Meyrelles; Elisardo C Vasquez; Agata L Gava
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

7.  Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.

Authors:  Izabela Zakrocka; Katarzyna M Targowska-Duda; Artur Wnorowski; Tomasz Kocki; Krzysztof Jóźwiak; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-29       Impact factor: 3.000

8.  Ketamine suppresses hypoxia-induced inflammatory responses in the late-gestation ovine fetal kidney cortex.

Authors:  Eileen I Chang; Miguel A Zárate; Maria B Rabaglino; Elaine M Richards; Maureen Keller-Wood; Charles E Wood
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

9.  EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

Authors:  Benjamin A Olenchock; Javid Moslehi; Alan H Baik; Shawn M Davidson; Jeremy Williams; William J Gibson; Abhishek A Chakraborty; Kerry A Pierce; Christine M Miller; Eric A Hanse; Ameeta Kelekar; Lucas B Sullivan; Amy J Wagers; Clary B Clish; Matthew G Vander Heiden; William G Kaelin
Journal:  Cell       Date:  2016-02-25       Impact factor: 41.582

10.  Ischemic Postconditioning and Subanesthetic S(+)-Ketamine Infusion: Effects on Renal Function and Histology in Rats.

Authors:  Marco A C de Resende; Alberto V Pantoja; Bruno M Barcellos; Eduardo P Reis; Thays D Consolo; Renata P Módolo; Maria A C Domingues; Alexandra R Assad; Ismar L Cavalcanti; Yara M M Castiglia; Norma S P Módolo
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.